跳至主要内容
临床试验/NCT03646851
NCT03646851已完成不适用

Impact of Aspergillus on Chronic Obstructive Pulmonary Disease Evolution

Centre Hospitalier Universitaire, Amiens8 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年3月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
100
试验地点
8
主要终点
presence of aspergillus in sputum or respiratory samples

研究概览

简要总结

This is a prospective multicenter cohort study which includes all consecutive COPD patients who come for a visit in one the participating pneumologist. They will have to do a sputum and to complete some questionnaries. Questionnaries will be redone by phone after 1 and 3 months and during the visit after 6 months. We will correlate aspergillus presence in sputum with quality of life (QoL), and COPD symptoms evaluated by questionnaires.

详细描述

Aspergillosis disease is a growing problem. These diseases are not yet uncommon in chronic obstructive pulmonary disease patients. (COPD).

Aspergillosis disease are very difficult to be diagnosed or treated. Isolation of aspergillus in sputum of patients is not always responsible of a real disease. Need of treatment is discussed. That is why, we will conduct a prospective cohort study to evaluate aspergillus rate in respiratory samples of COPD patients (GOLD stage III or IV)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • COPD patients GOLD stage III and IV

排除标准

  • Cystic fibrosis
  • Pulmonary fibrosis
  • hematological malignancy
  • known aspergilloma
  • allergic bronchopulmonary aspergillosis

结局指标

主要结局

presence of aspergillus in sputum or respiratory samples

时间窗: one year before inclusion

sputum examination

次要结局

  • Dyspnea with MMRC score(day of inclusion)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (8)

Loading locations...

相似试验